US Stock MarketDetailed Quotes

Cue Biopharma (CUE)

Watchlist
  • 17.6950
  • +1.0690+6.43%
Close Apr 24 16:00 ET
  • 17.6950
  • 0.00000.00%
Post 20:01 ET
57.60MMarket Cap-2.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma (CUE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
195.75%27.47M
1,292.26%21.94M
-35.58%2.15M
11.14%2.95M
-75.48%421K
69.16%9.29M
-13.45%1.58M
58.86%3.34M
92.33%2.66M
818.18%1.72M
Operating revenue
195.75%27.47M
1,292.26%21.94M
-35.58%2.15M
11.14%2.95M
-75.48%421K
69.16%9.29M
-13.45%1.58M
58.86%3.34M
92.33%2.66M
818.18%1.72M
Cost of revenue
Gross profit
Operating expense
6.11%53.99M
78.35%19.98M
-20.86%9.69M
-11.13%11.59M
-11.57%12.72M
-11.49%50.88M
-27.69%11.21M
-9.40%12.25M
-12.47%13.04M
6.03%14.39M
Selling and administrative expenses
11.37%16.24M
-14.15%3.45M
72.27%4.94M
4.85%3.68M
-0.31%4.17M
-12.56%14.59M
-12.76%4.02M
-21.34%2.87M
-17.51%3.51M
0.24%4.19M
-General and administrative expense
11.37%16.24M
-14.15%3.45M
72.27%4.94M
4.85%3.68M
-0.31%4.17M
-12.56%14.59M
-12.76%4.02M
-21.34%2.87M
-17.51%3.51M
0.24%4.19M
Research and development costs
3.99%37.74M
130.12%16.53M
-49.32%4.75M
-17.00%7.91M
-16.20%8.55M
-11.05%36.3M
-34.01%7.18M
-4.99%9.38M
-10.52%9.53M
8.60%10.2M
Depreciation amortization depletion
----
----
----
-33.33%4K
----
----
----
----
--6K
----
-Depreciation and amortization
----
----
----
-33.33%4K
----
----
----
----
--6K
----
Operating profit
36.24%-26.52M
120.33%1.96M
15.35%-7.54M
16.84%-8.64M
2.91%-12.3M
20.00%-41.59M
29.59%-9.63M
21.95%-8.91M
23.19%-10.38M
5.32%-12.67M
Net non-operating interest income expense
-45.52%450K
-21.90%107K
-5.16%147K
-27.83%153K
-86.92%42K
-41.67%826K
-65.58%137K
-62.56%155K
-36.14%212K
18.45%321K
Non-operating interest income
-50.25%807K
-45.52%158K
-35.28%222K
-53.63%198K
-69.75%170K
-39.05%1.62M
-67.96%290K
-51.00%343K
-24.29%427K
-12.32%562K
Non-operating interest expense
-55.15%357K
-66.67%51K
-60.11%75K
-79.07%45K
-46.89%128K
-36.06%796K
-69.82%153K
-34.27%188K
-7.33%215K
-34.86%241K
Other net income (expense)
-133.33%-31K
600.00%20K
-152.58%-51K
159.24%93K
-4K
97K
Special income (charges)
-133.33%-31K
600.00%20K
-152.58%-51K
----
----
159.24%93K
97.45%-4K
--97K
----
----
-Gain on sale of property,plant,equipment
-133.33%-31K
600.00%20K
-152.58%-51K
----
----
159.24%93K
97.45%-4K
--97K
----
----
Income before tax
35.83%-26.1M
121.96%2.09M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
Income tax
500K
0
Net income
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
Net income continuous Operations
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
Minority interest income
Net income attributable to the parent company
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
Basic earnings per share
61.11%-8.4
107.69%0.3
58.82%-2.1
55.00%-2.7
32.00%-5.1
35.14%-21.6
55.17%-3.9
29.17%-5.1
31.03%-6
13.79%-7.5
Diluted earnings per share
61.11%-8.4
107.69%0.3
58.82%-2.1
55.00%-2.7
32.00%-5.1
35.14%-21.6
55.17%-3.9
29.17%-5.1
31.03%-6
13.79%-7.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 195.75%27.47M1,292.26%21.94M-35.58%2.15M11.14%2.95M-75.48%421K69.16%9.29M-13.45%1.58M58.86%3.34M92.33%2.66M818.18%1.72M
Operating revenue 195.75%27.47M1,292.26%21.94M-35.58%2.15M11.14%2.95M-75.48%421K69.16%9.29M-13.45%1.58M58.86%3.34M92.33%2.66M818.18%1.72M
Cost of revenue
Gross profit
Operating expense 6.11%53.99M78.35%19.98M-20.86%9.69M-11.13%11.59M-11.57%12.72M-11.49%50.88M-27.69%11.21M-9.40%12.25M-12.47%13.04M6.03%14.39M
Selling and administrative expenses 11.37%16.24M-14.15%3.45M72.27%4.94M4.85%3.68M-0.31%4.17M-12.56%14.59M-12.76%4.02M-21.34%2.87M-17.51%3.51M0.24%4.19M
-General and administrative expense 11.37%16.24M-14.15%3.45M72.27%4.94M4.85%3.68M-0.31%4.17M-12.56%14.59M-12.76%4.02M-21.34%2.87M-17.51%3.51M0.24%4.19M
Research and development costs 3.99%37.74M130.12%16.53M-49.32%4.75M-17.00%7.91M-16.20%8.55M-11.05%36.3M-34.01%7.18M-4.99%9.38M-10.52%9.53M8.60%10.2M
Depreciation amortization depletion -------------33.33%4K------------------6K----
-Depreciation and amortization -------------33.33%4K------------------6K----
Operating profit 36.24%-26.52M120.33%1.96M15.35%-7.54M16.84%-8.64M2.91%-12.3M20.00%-41.59M29.59%-9.63M21.95%-8.91M23.19%-10.38M5.32%-12.67M
Net non-operating interest income expense -45.52%450K-21.90%107K-5.16%147K-27.83%153K-86.92%42K-41.67%826K-65.58%137K-62.56%155K-36.14%212K18.45%321K
Non-operating interest income -50.25%807K-45.52%158K-35.28%222K-53.63%198K-69.75%170K-39.05%1.62M-67.96%290K-51.00%343K-24.29%427K-12.32%562K
Non-operating interest expense -55.15%357K-66.67%51K-60.11%75K-79.07%45K-46.89%128K-36.06%796K-69.82%153K-34.27%188K-7.33%215K-34.86%241K
Other net income (expense) -133.33%-31K600.00%20K-152.58%-51K159.24%93K-4K97K
Special income (charges) -133.33%-31K600.00%20K-152.58%-51K--------159.24%93K97.45%-4K--97K--------
-Gain on sale of property,plant,equipment -133.33%-31K600.00%20K-152.58%-51K--------159.24%93K97.45%-4K--97K--------
Income before tax 35.83%-26.1M121.96%2.09M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M5.81%-12.35M
Income tax 500K0
Net income 34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M5.81%-12.35M
Net income continuous Operations 34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M5.81%-12.35M
Minority interest income
Net income attributable to the parent company 34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M5.81%-12.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M5.81%-12.35M
Basic earnings per share 61.11%-8.4107.69%0.358.82%-2.155.00%-2.732.00%-5.135.14%-21.655.17%-3.929.17%-5.131.03%-613.79%-7.5
Diluted earnings per share 61.11%-8.4107.69%0.358.82%-2.155.00%-2.732.00%-5.135.14%-21.655.17%-3.929.17%-5.131.03%-613.79%-7.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -